BeyondSpring (BYSI) Operating Expenses (2016 - 2026)
BeyondSpring's (BYSI) quarterly Operating Expenses came in at $1.7 million in Q2 2026, down 11.19% year-over-year from $1.9 million in Q2 2025, and down 22.45% quarter-over-quarter from $2.2 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Operating Expenses (2016 - 2026) Analysis & Trends
BeyondSpring has disclosed Operating Expenses across 9 years of filings, most recently posting $1.7 million for Q2 2026.
- In Q2 2026, Operating Expenses fell 11.19% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $8.3 million (down 3.11% YoY), while the FY2025 annual figure was $8.9 million, up 2.18% from the prior year.
- Operating Expenses came in at $1.7 million for Q2 2026 at BeyondSpring, down from $2.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $2.6 million in Q2 2024 to a low of $1.7 million in Q4 2024.
- Average Operating Expenses over 3 years is $2.2 million, with a median of $2.1 million recorded in 2024.
- The largest YoY upside for Operating Expenses was 52.71% in 2025 against a maximum downside of 26.2% in 2025.
- Over 3 years, Operating Expenses stood at $1.7 million in 2024, then soared by 52.71% to $2.6 million in 2025, then sank by 33.32% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $1.7 million in Q2 2026, $2.2 million in Q1 2026, and $2.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 505.13 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 452.50 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2021 | 10.83 Mn |
| Sep 30, 2021 | 18.69 Mn |
| Jun 30, 2021 | 20.32 Mn |
| Mar 31, 2021 | 17.76 Mn |
| Dec 31, 2020 | 18.80 Mn |
| Sep 30, 2020 | 15.35 Mn |
| Jun 30, 2020 | 13.62 Mn |
| Mar 31, 2020 | 16.63 Mn |
| Dec 31, 2019 | 15.29 Mn |
| Sep 30, 2019 | 9.70 Mn |